Choose a language and wait for the translated text.
In an intimation to the stock exchange, Sanofi said the notice alleges several discrepancies between the value of supplies reported in e-way bills and the corresponding disclosures, reported turnover and input tax claims made by the company for FY 2022-23.
Sanofi India served ₹16.4 crore tax notice over discrepancies in GST filing | PharmaVoice